Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

By Mariana Lazo, Ruben Hernaez, M. Eberhardt, Susanne Bonekamp, I. Kamel, Eliseo Guallar, Ayman A. Koteish, F. Brancati, J. Clark. American Journal of Epidemiology, 2013

796 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/5cd7cecb820e2c7a8743d1ccb8b67de7439e257b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Z. Younossi
2. R. Loomba
3. A. Sanyal
4. A. Lonardo
5. Fabio Nascimbeni
6. Megan H. Bair-Merritt
7. G. Targher
8. M. Rinella

In Epidemiology

1. R. Loomba
2. Z. Younossi
3. A. Sanyal
4. A. Lonardo
5. Fabio Nascimbeni
6. C. Estes
7. H. Razavi
8. Megan H. Bair-Merritt

In Hepatology

1. Z. Younossi
2. R. Loomba
3. A. Sanyal
4. A. Lonardo
5. C. Estes
6. H. Razavi
7. Megan H. Bair-Merritt
8. M. Rinella

Citations in the corpus

• Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps (2019, background): “( 88 ) US A To ta l 1 2, 45 4 20 -7 4 N o Eu ro pe an d es ce nt Co m pu te d N AF LD US p re va le nc e af te r a dj us tm en t f or o th er”
• Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease (2017, background): “(10) For this model, it was assumed that 30.0% of individuals aged 15 years of age in 2015 experienced NAFLD, with a large majority experiencing steatosis only.”